This information was published on 2026-08-24T08:32:29 for IP Right Registration Published.
| Field | Value |
| (210) | 2657190 (IR 1918919) |
| (220) |
27 Apr 2026
|
| (300) |
US, 27 Oct 2025, 99464435
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity. |
| (540) | EMPIXOS |
| (550) | Word |
| (730) |
Disc Medicine, Inc.
|
Find out more about publications on the About page.